CompletedNot Applicable

PRESERVE-Zenith® Iliac Branch System Clinical Study

United States40 participantsStarted 2011-01

Plain-language summary

The PRESERVE-Zenith® Iliac Branch System Clinical Study is a clinical trial to study the safety and effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation in combination with the Zenith® Connection Endovascular Stent/ConnectSX™ covered stent in the treatment of aorto-iliac and iliac aneurysms.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * An aortoiliac or iliac aneurysm of appropriate size * Unsuitable distal sealing site for a traditional Zenith® iliac leg graft within the common iliac artery Exclusion Criteria: * Less than 18 years of age * Inability or refusal to give informed consent * Disease considerations that would compromise patient safety or study outcomes * Unsuitable arterial anatomy

What they're measuring

Patients That Are Free From Patency-related Intervention

Timeframe: 6 Months

Trial details

NCT IDNCT01208415

SponsorCook Group Incorporated

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2012-10

Results submitted2017-07-18

View on ClinicalTrials.gov More Aorto-iliac Aneurysms trials